Rayo Pharma Private Limited

Manufacturer and distributor of various pharmaceutical and chemical products in India and abroad.

2018 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Rayo Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 6 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 192.20%
  • Profit Growth 243.68%
  • Ebitda 247.11%
  • Net Worth 59.30%
  • Total Assets -18.37%

About Rayo Pharma

Rayo Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 October 2018 (Six years and six months 20 days old ). Its registered office is in Ahmedabad, Gujarat, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.

Jigneshkumar Patel, Ashik Sanghvi, and Munir Shah serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U33119GJ2018PTC104863

  • Company No.

    104863

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    23 Oct 2018

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma
Company report

Rayo Pharma Private Limited

Explore comprehensive data for Rayo Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Rayo Pharma?

Board Members (3)

NameDesignationAppointment DateStatus
Jigneshkumar Patel Country flag representing In Director 23-Oct-2018Current
Ashik Sanghvi Country flag representing In Director 23-Oct-2018Current
Munir Shah Country flag representing In Director 23-Oct-2018Current

Financial Performance of Rayo Pharma.

Rayo Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 192.2% increase. The company also saw a substantial improvement in profitability, with a 243.68% increase in profit. The company's net worth Soared by an impressive increase of 59.3%.

Rayo Pharma revenue growth over time
Rayo Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
192.20%
Revenue from Operations
196.17%
Total Assets
-18.37%
Profit or Loss
243.68%
Net Worth
59.30%
EBITDA
247.11%

What is the Ownership and Shareholding Structure of Rayo Pharma?

In 2023, Rayo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Rayo Pharma?

Unlock and access historical data on people associated with Rayo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Rayo Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rayo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rayo Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rayo Pharma

Recent activity within the organization

  • Annual General Meeting

    Rayo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Rayo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.

  • Director Appointment

    Jigneshkumar Arvindbhai Patel was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 6 years 6 months .

  • Director Appointment

    Ashik Dhirubhai Sanghvi was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 6 years 6 months .

  • Director Appointment

    Munir Mahendrakumar Shah was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 6 years 6 months .

  • Company Incorporation

    Rayo Pharma Private Limited was registered on 23 Oct 2018 with Roc Ahmedabad & aged 6 years 6 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Rayo Pharma Private Limited?

    Rayo Pharma Private Limited was incorporated on 23 Oct 2018.

  • What is authorized share capital and paid-up capital of Rayo Pharma Private Limited?

    The authorized share capital of Rayo Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.

  • Who are the current board members & directors of Rayo Pharma Private Limited?

    Currently 3 directors are associated with Rayo Pharma Private Limited.

    • Jigneshkumar Arvindbhai Patel
    • Ashik Dhirubhai Sanghvi
    • Munir Mahendrakumar Shah

  • What is the registered address of Rayo Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Rayo Pharma Private Limited is 12 Navjivan (Kalyan) Co Op H Soc Near Nagari Hospital Ellis Bridge, India, Ahmedabad, Gujarat, 380006.

  • What is the corporate identification number (CIN) and company number of Rayo Pharma Private Limited?

    The corporate identification number (CIN) of Rayo Pharma Private Limited is U33119GJ2018PTC104863 and the company number is 104863 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Rayo Pharma Private Limited?

    The Official website of Rayo Pharma Private Limited is https://www.rayopharma.in

  • What has been the recent revenue trend for Rayo Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Rayo Pharma Private Limited has risen by 192.20%.

  • What change has been observed in the net worth of Rayo Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Rayo Pharma Private Limited has experienced an upsurge of 59.30%.

  • When was the last Balance Sheet of Rayo Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Rayo Pharma Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development